​Trans Youth Are Not a Thought Experiment

Puberty Blockers, Recorded Distress, and the Politics of Pretending Not to Know

The demand for more evidence would be easier to take seriously if new evidence ever changed the argument. Instead, every study on gender-affirming care is dropped into the same exhausting cycle: the sample is too small, the follow-up is too short, the people studied are too specific, the results are self-reported, the researchers are biased, or the entire medical field has somehow been tricked into participating in a coordinated attack on children. Then a nationwide study using the insurance records of 231,783 young people comes along, and suddenly the problem is that insurance records cannot tell us enough about the people behind them. That criticism is not entirely wrong, but the pattern is difficult to ignore. No evidence is ever quite good enough when the conclusion interferes with what people have already chosen to believe. The study, published in JAMA Network Open on July 17, 2026, found that transgender youth had much higher recorded rates of mood disorders and suicidal thoughts and behaviours than cisgender youth, while puberty-blocker treatment was associated with lower adjusted odds of both among transgender youth. That does not mean puberty blockers are a miracle, nor does it answer every question surrounding their long-term use, but it does complicate the popular claim that this care is obviously creating the mental-health crisis surrounding transgender children. 

The crisis was already there. In the study, being transgender was associated with more than four times the adjusted odds of a mood-disorder diagnosis and more than twelve times the adjusted odds of suicidal thoughts or behaviours compared with being cisgender. At some point, the conversation has to move beyond whether these children are distressed enough to deserve attention and toward why so many adults remain more interested in debating their identity than addressing what is happening to them.

Highlight a line that stuck with you.

www.thesocialdeep.com

Share Card Save Image

The researchers looked at insurance claims from 2016 through January 2025 and compared transgender and cisgender youth with and without puberty-blocker prescriptions. Of the 41,472 transgender youth included in the analysis, only 1,260 had a recorded prescription, or just over three percent. The estimated yearly rate was between one and four patients per 100,000, which makes the size of the political panic look even more absurd than it already did. Entire campaigns have been built around the idea that children are being pushed through some massive medical experiment, while the treatment at the center of the panic was rarely recorded even within this very large sample. Among transgender youth, a blocker prescription was associated with 48 percent lower adjusted odds of a mood-disorder diagnosis and 80 percent lower adjusted odds of suicidality. The raw numbers were a little messier, because research involving actual human beings usually is: suicidal thoughts and behaviours were recorded for 3.65 percent of transgender youth with blocker prescriptions compared with 5.65 percent without them, while mood disorders were recorded for 33.81 percent of the blocker group and 30.57 percent of those without blockers. The lower mood-disorder finding appeared after researchers accounted for differences such as age, insurance, region, economic disadvantage, length of time in the database, and state policy conditions. That does not make the finding fake, but it does mean the headline needs context. The clearest pattern in the raw data involved lower recorded suicidality; the mood result relied more heavily on the statistical model. Both deserve to be discussed without pretending the study said more, or less, than it actually did.

Insurance claims can reveal patterns across a huge population, but a billing code is not a diary. It cannot tell us when a young person first began struggling, how intense the distress became, whether it changed after treatment, or what else was happening in their life. It cannot measure the difference made by a supportive family, a safer school, stable insurance, transportation to appointments, an affirming clinician, or simply having an adult take the young person seriously. Those things may affect both who receives puberty blockers and who has better mental-health outcomes, which is why the study shows an association rather than proving that the medication alone caused the difference. That limitation matters, but it is not the same as the study meaning nothing. Earlier research has also found links between access to gender-affirming medical care and lower depression or suicidality, including a prospective study that followed 104 transgender and nonbinary young people for one year, although that study combined puberty blockers with gender-affirming hormones and took place within one specialised clinic. Another study found lower lifetime suicidal ideation among transgender adults who had wanted and received puberty suppression as adolescents, but it relied on adults remembering and reporting past experiences. Systematic reviews have reasonably described the overall evidence as very low certainty because the available studies are mostly observational, small, or vulnerable to differences between the people who received treatment and those who did not. That is a reason to conduct better research, not a reason to treat every existing finding as disposable. Low certainty does not mean no evidence; it means the evidence has limits, and those limits should shape how confidently we speak. Somehow, people who insist on that distinction when a study suggests benefit are often much less careful when a politician claims that children are being manipulated, confused, recruited, or permanently harmed. Apparently, scientific restraint is only required when it threatens the moral panic.

Puberty blockers were also never going to erase the mental-health gap because puberty is not the only thing transgender youth are being asked to survive. A prescription may delay unwanted physical changes, but it cannot stop a family from treating authenticity like betrayal, prevent classmates from turning difference into entertainment, or make a school safer when adults have decided that a child’s name, clothing, bathroom use, and participation in ordinary life are political statements. It cannot keep young people from hearing lawmakers describe their existence as evidence of social decay, nor can it undo the effect of watching strangers argue that their bodies should be controlled for their own good. The study points to bullying, discrimination, stigma, isolation, and family or social rejection as part of the larger mental-health burden carried by transgender youth. Those are not side issues sitting outside the “real” medical conversation. They are part of the medical conversation because nervous systems respond to rejection, instability, humiliation, fear, and ongoing threat whether society wants to call those experiences social, political, or personal. We keep creating conditions that produce distress and then pointing to the distress as proof that something is wrong with the person experiencing it. The same structure has been used against queer people, women, racialized communities, disabled people, and nearly anyone else whose suffering would require the surrounding system to admit that it is not as fair, neutral, or harmless as it pretends to be. Transgender youth are expected to show perfect psychological stability while being raised in a culture that repeatedly reminds them that healthcare, family acceptance, public safety, and basic belonging may disappear depending on an election. When treatment reduces only part of that burden, the pain that remains is treated as proof that the treatment failed. Medicine cannot repair an injury society keeps reopening, but that does not make the care useless. It means the medication was never the only intervention needed.
​
None of this requires pretending puberty blockers are right for every transgender young person, free of physical tradeoffs, or capable of guaranteeing a particular future. Young people deserve individual assessment, honest information, qualified clinicians, appropriate family involvement, mental-health support, continued monitoring, and clear conversations about bone health, physical development, fertility-related concerns, treatment timing, uncertainty, and what happens if their needs or understanding change. What they do not deserve is a political system using medical complexity as an excuse to erase every individual circumstance and replace clinical decisions with a blanket ban. There is something deeply backwards about declaring young people incapable of knowing anything meaningful about their own bodies while assuming lawmakers can understand those bodies through campaign speeches and committee hearings. The child is called confused, the parent is called reckless, the clinician is called ideological, and the researcher is called compromised until the only person left with any credibility is the politician who reached a conclusion before hearing the evidence. That is not caution. It is a system designed to make sure the people closest to the situation are always the easiest to dismiss. This study does not end the discussion, but it adds to the evidence that puberty blockers may reduce some forms of recorded distress, particularly suicidality, and it gives us no reasonable basis for pretending that withholding care is harmless or neutral. The research should continue, the care should remain accountable, and the findings should not be stretched beyond what the study can support. Transgender youth, however, should not be forced to survive preventable suffering while adults perform concern and wait for an impossible level of certainty. Protection listens to the person being protected. Anything that requires their silence, obedience, and disappearance is not protection; it is control wearing a softer face.